Advancing precision oncology in soft tissue sarcomas: The role of iTRAC in metastatic risk stratification and treatment personalization.

Adaptive AI-driven clinical decision-making in oncology through digital twins and large-scale imaging biomarkers. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced major new features for the Guardant ...

Guardant Health, Inc. (NASDAQ:GH) has introduced major upgrades to its Guardant360 Liquid biopsy test, significantly ...

Conclusion: ROSE effectively differentiates benign from malignant lesions and accurately classifies SCLC and NSCLC during bronchoscopic biopsy. While useful for preliminary subtyping of SCC and AC, ...

For decades, gynecologic cancer treatment has used aggressive surgical intervention and chemotherapy. These methods often ...

The Cook Islands declared a dengue outbreak in Rarotonga last week. Other Pacific nations including Sāmoa, Tonga, and Fiji ...

In conversation with Fierce Biotech’s Chris Hayden, Austin Read, head of PPD™ CorEvitas™ Precision Medicine, Thermo Fisher ...

The objectives of the present study were the subtyping of Campylobacter jejuni subsp. jejuni strains obtained from humans and different animal species using PCR-RFLP, and the detection, by means of ...